Introduction
and BH2 regions and significant homology to Bcl-2 family members or any other protein, except for a stretch of eight Apoptosis, a morphologically distinguished form of proamino acids that exhibits high homology with BH3 regions. grammed cell death, is critical not only during development Hrk structurally resembles Bik/Nbk, another BH3-conand tissue homeostasis but also in the pathogenesis of a taining protein which was identified recently as an intervariety of diseases including cancer, autoimmune disease, acting partner of the adenovirus E1B 19K protein and viral infection and neurodegenerative disorders (ThompBcl-2 (Boyd et al., 1995; Han et al., 1996b) . Beyond the son, 1995). The precise mechanisms that regulate apoptosis conserved BH3 region, however, Bik/Nbk and Hrk do not have not been elucidated; however, it appears that this share any significant amino acid homology. Expression of form of cell death is controlled by a genetic program which is activated in the dying cell  Hrk induced cell death which was repressed by Bcl-2 and Bcl-X L . Deletion of the conserved BH3 region in Hrk abolished its ability to interact with Bcl-2 and Bcl-X L , and dramatically diminished its killing activity when compared with wild-type Hrk. Because Hrk lacks conserved BH1 and BH2 domains that define Bcl-2 family members, we propose that Bik/Nbk and Hrk represent a novel class of proteins that regulate apoptosis at least in part by interacting selectively with survival-promoting Bcl-2 and Bcl-X L .
Results
Two-hybrid screening for proteins that bind to Bcl-2 reveals a novel protein that interacts with anti-apoptosis proteins Bcl-2 and Bcl-X L but not with the GAL4-Bcl-2 bait. Plasmids recovered from the original yeast strain were used in a co-transformation assay with the original GAL4-Bcl-2 bait or control heterologous baits to discard false-positive clones. Twenty one cDNAs control plasmid. In these initial experiments, the entire (designated BP1-21) were found to contain inserts of harakiri sequence that was fused to the GAL4 DNAdifferent sizes (from 1.3 to 0.7 kb) that interacted with binding domain was cloned into expression plasmids the GAL4-Bcl-2 bait but not with control baits. These to produce Flag-Hrk. Immunoprecipitates were prepared cDNA clones were characterized by restriction enzyme using hamster anti-Bcl-2 monoclonal antibody and submapping and nucleotide sequence analysis. As expected, jected to SDS-PAGE and immunoblotting using antimultiple clones encoded proteins which are known to Flag or Bcl-2 antibody. Immunoblotting with anti-Bcl-2 associate with Bcl-2 in mammalian cells. Seven cDNAs antibody revealed that Flag-Hrk was co-immunoprecipiencoded Bad, three encoded Bax and two encoded Bik/ tated with Bcl-2 ( Figure 2A ). Control immunoblotting Nbk (Oltvai et al., 1993; Boyd et al., 1995; Yang et al., with anti-Bcl-2 antibody confirmed that Bcl-2 was 1995; Han et al., 1996b) . Four cDNAs encoded a Rasimmunoprecipitated in lysates of cells transfected with the related protein (Yamagata et al., 1994) . The two-hybrid bcl-2 plasmid (Figure 2A ). The Hrk-Bcl-2 interaction was screen also yielded five cDNA clones with novel nucleotide specific in that it required co-expression of both Bcl-2 sequences. Restriction enzyme and sequence analysis and Flag-Hrk, and was not detected when the lysate was revealed that four of the novel positive clones contained immunoprecipitated with control antibody (Figure 2A ). identical inserts of 712 bp fused to the GAL4 DNATo verify the interaction, we performed reciprocal experibinding domain. One of these four cDNA clones was ments using anti-Flag antibody to immunoprecipitate Flagcharacterized further. We have named this novel gene Hrk, followed by Western blot with anti-Bcl-2 antibody. 'harakiri' and the product that it encodes Hrk, after the In agreement with the reverse experiment, Bcl-2 coJapanese suicide ritual (see below).
immunoprecipitated specifically with Flag-Hrk (Figure To characterize the specificity of the Hrk interactions 2B). further, we determined the ability of Hrk to interact with To determine if Hrk associates with Bcl-X L in mammaBax, Bak and Bcl-X S , three Bcl-2-related proteins that lian cells, we performed immunoprecipitation experiments promote cell death. In the yeast two-hybrid system, Hrk similar to those performed to assess the Hrk-Bcl-2 interinteracted with Bcl-2 and Bcl-X L but not with Bax, Bak action. After transfection of 293T cells with expression or Bcl-X S (Figure 1 ). These results indicate that Hrk plasmids producing a Flag-tagged Hrk protein and Bclselectively interacts with Bcl-2 family members such as X L or control plasmid, immunoprecipitates were prepared Bcl-2 and Bcl-X L which are functionally related in that using anti-Bcl-X antibody and subjected to SDS-PAGE they are capable of inhibiting apoptosis. Importantly, Hrk immunoblotting using anti-Flag antibody. Importantly, failed to associate with Bcl-X S , an alternative form of Flag-Hrk was co-immunoprecipitated specifically with Bcl-X, that lacks an internal region of 62 amino acids Bcl-X L ( Figure 2C ). To confirm the interaction, we perthat is required for Bcl-X L protective function (Boise formed reciprocal experiments using anti-Flag antibody et al., 1993) .
to immunoprecipitate Flag-Hrk, followed by Western blot with anti-Bcl-X antibody. In agreement with the reverse Hrk interacts with Bcl-2 and Bcl-X L in mammalian experiment, Bcl-X L co-immunoprecipitated specifically cells with Flag-Hrk ( Figure 2D ). We also tested if Hrk interacts To confirm that Hrk associates with Bcl-2 and Bcl-X L in with Bax in 293T cells and found that Flag-Hrk failed to mammalian cells, a 293T human kidney cell line was co-immunoprecipitate with Bax, confirming our results in transiently co-transfected with expression plasmids producing a Flag-tagged Hrk protein and Bcl-2, Bcl-X L or the yeast assay (data not shown). harakiri encodes a novel protein with a conserved and predicted to be present in other Bcl-2 family members ( Figure 3C ). A region of 28 hydrophobic residues that BH3 region but lacking BH1 or BH2 domains To confirm the sequence obtained by the two-hybrid assay, may serve as a membrane-spanning domain was identified at the COOH-terminus of the Hrk coding region (Figure a 9-week embryo human cDNA library was screened by hybridization with a labeled harakiri probe. Forty positive 3A). cDNA clones were identified and characterized by restriction mapping, PCR analysis and sequencing. Analysis of harakiri displays a highly restricted expression in human tissues the longest cDNAs revealed inserts of 716 bp essentially identical in sequence to that observed previously fused to To characterize harakiri further, its expression pattern was examined by Northern blot analysis using a harakiri probe the GAL4 DNA-binding domain. A single nucleotide difference C→T at position 334 of the harakiri cDNA of various RNA samples isolated from human adult tissues. A major 0.7 kb transcript was detected in all lymphoid was noted between the coding sequences obtained from the HeLa and embryo cDNA libraries ( Figure 3A ). This tissues tested but was expressed predominantly in bone marrow and spleen ( Figure 4 ). Further analysis showed nucleotide difference did not change the amino acid sequence of Hrk, reflecting perhaps a gene polymorphism.
that harakiri mRNA was also expressed in pancreas and at very low or undetectable levels in kidney, liver, lung Northern blot analysis of mouse and human tissues using a labeled harakiri probe identified a major mRNA species and brain (data not shown). of~0.7 kb in certain tissues (see below). Taken together, these results suggest that the isolated cDNA clones are
The Flag-Hrk protein is a non-nuclear intracellular protein full-length. The cDNAs encode an open reading frame of 91 amino acids ( Figure 3A ). In the 3Ј untranslated region, In order to begin to assess the subcellular localization of Hrk, we transiently transfected a Flag-harakiri construct an ATTTA sequence motif for RNA destabilization (Shaw and Kamen, 1986 ) and a poly(A) tail were identified.
into 293 cells and determined the intracellular localization of the Flag-Hrk protein by laser scanning confocal microInitial DNA searches using the NCBI BLAST program revealed that the nucleotide sequence was novel in that scopy. Analysis of labeled cells with anti-Flag monoclonal antibody revealed that Flag-Hrk displays a labeling pattern they did not reveal significant homology to any known gene or translated products in the databases. However, which was granular and extranuclear, consistent with a localization confined to membranes of intracellular close inspection of the Hrk protein revealed a stretch of eight amino acids, Hrk 37-44, with high homology to a organelles ( Figure 5A ). The labeling pattern of Hrk was similar to that previously reported for Bcl-2 and Bcl-X L , BH3 motif. This conserved region is shared by Bcl-2 family members (Chittenden et al., 1995b; Zha et al., suggesting that Hrk, Bcl-2 and Bcl-X L localize to similar intracellular compartments in mammalian cells (Krajewski 1996) . The BH3 region of Hrk was contained within a predicted α-helix which has been described recently González-García et al., 1994) . The specificity of the labeling was determined by assessing the staining the crystal structure of Bcl-X L (Muchmore et al., 1996) , Fig. 4 . Expression of harakiri mRNA by Northern blot analysis. A filter loaded with 2 μg of poly(A) RNA from various tissues of the immune system was hybridized with the entire harakiri cDNA probe labeled with 32 P, washed with 0.2ϫ SSC at 65°C for 1 h. The filter was exposed to X-ray film for 12 h. 28S rRNA, 18S rRNA and the major transcript of 0.7 kb are indicated by arrowheads. PBL, peripheral blood leukocytes.
cell survival ( Figure 6A , C, E and G). Significantly, co-expression of Bcl-2 or Bcl-X L inhibited the death- Hrk requires a region of 16 amino acids containing BH3 to interact with Bcl-2 and Bcl-X L To determine the ability of Hrk to associate with Bcl-2 or pattern obtained after transfection with a control Flagtagged GATA-1 expression plasmid. Staining of the GATABcl-X L through BH3, we engineered a mutant form of Hrk lacking BH3. A deletion mutant was designed to 1 protein with anti-Flag antibody revealed a nuclear labeling pattern, as expected for a nuclear transcriptional eliminate residues 34-49 of Hrk, a predicted α-helix, to minimize secondary effects on folding of the Hrk protein. factor ( Figure 5B ).
The deleted residues contained the most conserved amino acids of the BH3 homology region of Hrk (Figures 3C Expression of Hrk induces rapid cell death which is repressed by Bcl-2 and Bcl-X L and 7A). Expression plasmids producing wild-type or mutant Flag-tagged Hrk and Bcl-2 or Bcl-X L were transiThe effect of harakiri on cell survival was examined initially in 293T cells using a transient transfection assay.
ently co-transfected into 293T cells. Immunoprecipitates were prepared using anti-Flag to recognize wild-type Transfection of a harakiri expression plasmid into 293T cells resulted in a dramatic loss of cell viability at 36 h and mutant Flag-Hrk and subjected to SDS-PAGE and immunoblotting using anti-Bcl-2 and anti-Bcl-X antipost-transfection ( Figure 6B and F) . This was specific in that transfection of 293T cells with empty vector, bcl-2 bodies. Deletion of residues 34-49 (Hrk mutant ΔBH3) completely eliminated the ability of Hrk to interact with or bcl-x L expression plasmids did not have any effect on Bcl-2 and Bcl-X L ( Figure 7B ). To confirm these results,
In agreement with the reverse experiment, wild-type Hrk but not mutant Hrk co-immunoprecipitated specifically we performed reciprocal experiments using anti-Bcl-2 antibody, followed by Western blot with anti-Flag antibody.
with Bcl-2 ( Figure 7C ). Analysis of total lysates from the same cellular extracts by immunoblotting confirmed that with mutant Hrk ΔBH3 nor control plasmid displayed nuclear fragmentation, a cytological change associated 293T cells transfected with the corresponding plasmids expressed Bcl-2, Bcl-X L , wild-type and mutant Hrk prowith apoptosis ( Figure 8B ). teins ( Figure 7D ).
Discussion

The BH3 domain of Hrk is required for the induction of cell death
We have identified harakiri, a novel regulator of apoptosis that exhibits death-inducing activity in mammalian cells. To determine if the BH3 domain of Hrk is necessary to induce cell death, we compared the killing activity of Hrk interacts with Bcl-2 and Bcl-X L , two death-repressing Bcl-2 family members that play essential roles in mainwild-type and mutant Hrk proteins by a transient transfection assay in 293T cells. The cells were co-transfected with taining cell survival in embryonic and adult tissues (Veis et al., 1993; Motoyama et al., 1995) . Hrk shares homology a reporter plasmid expressing GFP (green fluorescence protein), in combination with either an expression plasmid with Bcl-2 in the BH3 domain but, unlike most other Bcl-2 family members, it lacks conserved BH1 and BH2 encoding Hrk proteins or control plasmids. The cell killing activity of wild-type and mutant Hrk was measured by a regions. The BH3 region appears to represent a critical domain for interaction with Bcl-2 family members and reduction in the number of cells that express the reporter GFP protein relative to that obtained by transfection regulation of apoptosis. For example, BH3 is required for death-promoting Bax and Bak to associate with Bcl-2 and with a control expression plasmid. The results of these experiments showed that deletion of residues 34-49 of Bcl-X L (Chittenden et al., 1995a; Han et al., 1996a; Simonian et al., 1996; Zha et al., 1996) . Moreover, deletion Hrk (Hrk mutant ΔBH3) dramatically reduced the ability of Hrk to kill 293T cells, when compared with the activity of BH3 prevented the killing activity of Bak and expression of a 30 amino acid region of Bak containing BH3 linked exhibited by wild-type Hrk ( Figure 8A ). Furthermore, expression of Bcl-2 or Bcl-X L inhibited the killing activity to a membrane anchor sequence was sufficient for cell killing activity in transient assays (Chittenden et al. , of wild-type Hrk, confirming the results presented in Figure 6 . The loss of viability and the morphology of the 1995b). In our studies, a 16 amino acid region of Hrk encompassing BH3 was required for Hrk to interact with cells observed after transfection with Hrk plasmids in Figure 6 suggested that Hrk may induce apoptotic cell Bcl-2 and Bcl-X L , and its deletion eliminated or greatly reduced the killing activity of Hrk. In addition, these death. To determine if the cell death activated by transient Hrk expression was caused by apoptosis, the nuclei of studies demonstrate that a region of 62 residues containing the BH1 and BH2 regions in Bcl-X L is essential for its 293T cells were stained with acridine arange and ethidium bromide. Cells transfected with wild-type Hrk but not binding to Hrk since Bcl-X S , an alternative form of Bcl-X lacking these conserved domains, failed to associate Oncogenic signals such as deregulated c-Myc or adenovirus E1A can promote or induce apoptosis in cell lines with Hrk.
Susceptibility of a cell to apoptotic signals appears to (Askew et al., 1991; White et al., 1991; Evan et al., 1992) . Thus, it is conceivable that in tumor cells, apoptotic be regulated in part by the relative levels and competing dimerizations of death-suppressing and death-promoting signals are constitutively expressed, although repressed by Bcl-2 and/or Bcl-X L . Consistent with this is the Bcl-2 family members (Oltvai and Korsmeyer, 1994; . How could Hrk activate cell death? Two observation that expression of Bcl-X S , a functional inhibitor of Bcl-2 and Bcl-X L (Boise et al., 1993) , activates non-exclusive models could be proposed to explain the role of Hrk in cell death. Hrk could be an effector apoptosis in a wide variety of cancer cells (Clarke et al., 1995) . Thus, physical inactivation of Bcl-2 and Bcl-X L molecule with intrinsic death-inducing activity, and deathsuppressing Bcl-2 and Bcl-X L may serve as dominant by Hrk could similarly unleash endogenous death signals leading to execution of the apoptotic program. This inhibitors. In support of this model, overexpresssion of Bcl-2 or Bcl-X L inhibited the killing activity of Hrk.
hypothesis is consistent with recent observations in mutant mice lacking Bcl-2 and Bcl-X (Veis et al., 1993 ; Motoyama Alternatively, Hrk could promote cell death by inhibiting the protective activity of Bcl-2 and Bcl-X L and perhaps et al., 1995) . Mice deficient in Bcl-X developed massive apoptosis of neural and hematopoietic tissues and died at other functional homologs. Inactivation of Bcl-2 and Bcl-X L would require the interaction of these survival proteins E12-13 of embryonic development (Motoyama et al., 1995) , whereas newly born Bcl-2-deficient mice exhibited with Hrk and be mediated by the formation of Bcl-2-Hrk and/or Bcl-X L -Hrk complexes. The analysis of the Hrk fulminant apoptosis of lymphoid tissues (Veis et al., 1993) . Thus, in addition to cancer cells, expression of Bcl-X or ΔBH3 mutant strongly supports the latter model in that a region of 16 residues containing the BH3 domain required
Bcl-2 appears necessary to counter death signals that arise during normal development. The precise mechanism of for Hrk to interact with Bcl-2/Bcl-X L was also necessary for Hrk killing activity. However, these studies cannot death triggered by Hrk needs to be determined, but we hypothesize that it involves the activation of interleukin rule out that Hrk could also act as a death effector molecule as it is formally possible that the 16 amino acid 1-β converting enzyme-like proteases, a step which appears to be downstream of Bcl-2 and Bcl-X L in the death deletion in Hrk directly or indirectly also affects an intrinsic death-inducing activity. Similarly, deletion mutant pathway (Chinnaiyan et al., 1996) . harakiri is the second member of a class of cell analysis of Bak has shown that elimination of BH3 greatly diminished the killing activity of Bak (Chittenden et al., death regulatory genes that also include bik/nbk. Unlike 'classical' bcl-2 family members, the proteins that they 1995b). Thus definitive evidence for the second model will require additional mutational studies and analysis of encode lack conserved BH1, BH2 or BH4 regions but share the BH3 domain. Our studies indicate that the BH3 cells deficient in Hrk. Bcl-X L . Although Hrk and Bik/Nbk share both a BH3
A 9-week human embryo λgt11 cDNA library (Swaroop and Xu, 1993) domain and a hydrophobic region at the COOH-terminus was screened by hybridization with a 32 P-labeled cDNA containing the predicted to mediate attachment to intracellular mementire coding region of harakiri. Approximately 1ϫ10 6 cDNA clones were screened by standard procedures, and positive phage clones were branes, these proteins are distinct and do not share purified by sequential plating and hybridization. DNA inserts were additional amino acid homology. Thus, it is possible that characterized by PCR amplification of phage DNA from purified plaques, there are subtle differences in the function of Hrk and restriction enzyme mapping of phage DNA inserts and dideoxy Bik/Nbk. In this respect, it has been shown that Bcl-X S sequencing.
interacts with Bik/Nbk (Boyd et al., 1995) , but our analysis previously described (Merino et al., 1995; Simonian et al., 1996) . For immunoprecipitations, 1ϫ10 7 cells were lysed in NP-40 isotonic lysis buffer (Oltvai et al., 1993) at 38 h after transfection and the lysates were rotated with 10 μg/ml of anti-Flag M2 monoclonal antibody
Materials and methods
(Scientific Imaging Systems, Rochester, NY), hamster anti-Bcl-2 monoclonal antibody (Hockenbery et al., 1991) , rabbit anti-Bcl-X (Boise Screening for Bcl-2-interacting proteins by the yeast et al., 1995) or control Ig overnight at 4°C. Then 5% (v/v) of protein two-hybrid system A-Sepharose 4B (Zymed Laboratories Inc., San Francisco, CA) was A HeLa cDNA library fused to the GAL4 activation domain of the added for an additional hour of incubation by rotation. Immune complexes pGAD-GH vector (Hannon et al., 1993) was screened for proteins that were centrifuged and washed with excess cold NP-40 isotonic lysis interact with human Bcl-2, using the HF7c yeast reporter strain (Feilotter buffer at least four times, separated on a 15% SDS-polyacrylamide gel et al., 1994) . Briefly, the pGAD library plasmid was transformed into and immunoblotted with anti-Bcl-2, anti-Flag, rabbit anti-Bcl-X or HF7c yeast cells harboring the pGBT-9-bcl-2 bait plasmid by standard control Ig. transfection procedures. Transformed HF7 cells were plated on medium lacking tryptophan, leucine and histidine. A total of 3ϫ10 6 library clones Northern blot analysis were screened for growth in selection medium and assayed for β-A 716 bp harakiri cDNA was radiolabeled by the random priming galactosidase activity. Positive clones were picked and yeast plasmid method using a commercial kit (Boehringer Mannheim, Indianapolis, DNA from individual clones was used to transform Escherichia coli IN) and applied for analysis of human multiple tissue blots (Clontech HB101 (leuB -) cells. Library plasmids were recovered selectively from Laboratories, Palo Alto, CA) according to the manufacturer's instructions. bacterial colonies by growth in media lacking leucine. False-positive clones were eliminated by testing for interaction with empty vector Laser scanning confocal microscopy and fluorescence pGBT-8 and irrelevant 'baits'. cDNA inserts in the plasmid were staining of nuclear DNA characterized by restriction enzyme mapping and nucleotide sequence 293 cells were transfected with pCDNA3-Flag-Hrk, pCDNA3-Flaganalysis using an automated DNA sequencer (Applied Biosystems GATA-1, or empty vector as described above. Twenty four hours after Model 373A).
transfection, cells were incubated with anti-Flag monoclonal antibody or control mouse Ig for 1 h at 23°C and the labeling visualized with fluorescein-conjugated goat anti-mouse IgG. After washing, the cells Plasmid construction were mounted in Slowfade (Molecular Probes, Eugene, OR) and examPlasmids expressing hBcl-X L or hBcl-X S (Boise et al., 1993) , mBax ined using a BioRad MRC 600 scanning confocal microscope equipped (Oltvai et al., 1993) and hBak (Farrow et al., 1995) in pGBT-9 were with an argon-xenon laser (González-García et al., 1994) . Staining of constructed by PCR amplification of plasmid cDNA to incorporate nuclei with acridine orange and ethidium bromide was performed as restriction sites, followed by ligation of the amplified DNA fragments described previously (Duke and Cohen, 1994) . in-frame with the GAL4 DNA-binding domain of pGBT-9. The authenticity of the GAL4 fusion plasmids was confirmed by dideoxy sequencing.
Cell death assays The mammalian expression plasmids SFFV-Flag-hBcl-2, SFFV-Flag-293T, 293 and HeLa cells were co-transfected by a calcium phosphate hBcl-x L and SFFV-Flag-mBax have been described (Merino et al., 1995;  method with pRK7.GFP, a reporter plasmid expressing GFP (a gift of Simonian et al., 1996) . Three different constructs were generated to Roger Y.Tsien), in combination with an expression plasmid encoding Hrk, express harakiri sequences. In an initial construction, a Flag epitope Bcl-2, Bcl-X L or control plasmid. The number of plasmids transfected is sequence was attached to nucleotide 7 of the 5Ј untranslated region of indicated in the figure legends. Killing activity was determined at 48 h the harakiri cDNA to generate Flag-Hrk16K by PCR using pGAD-GHafter transfection and based on the analysis of 5ϫ10 3 cells by FACScan harakiri plasmid as a template (see Figure 3A) . The Flag sequence in flow cytometry (Becton Dicknson, Mountain View, CA). In the assay, Hrk16K was in-frame with the amino-terminus of Hrk, resulting in a the cell killing activity was manifested by a reduction in the number of fusion protein with a predicted size of 16 kDa. In a second construction, cells that express GFP relative to that obtained by transfection with the a Flag-Hrk insert was constructed by introducing a Flag epitope tag at control expression plasmid. the amino-terminus of Hrk by PCR. A deletion of amino acids 34-49 that includes the BH3 domain of Hrk was generated by a two-step PCR Accession number mutagenesis method as described (Simonian et al., 1996) . A Flag epitope
The accession number for the nucleotide sequence of harakiri cDNA tag was attached to the amino-terminus of mutated Hrk protein to reported in this paper is U76376. generate Flag-Hrk ΔBH3. A Flag epitope tag was attached to the aminoterminus of a control cDNA clone BP25 (N.Inohara, L.Ding and G.Núñez, unpublished data) by PCR. The Flag-tagged inserts were
